Medical Condition News

RSS

Gut mRNA tech supercharges vaccine and GLP-1 delivery

From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, to carry treatments where they need to go.

5 Oct 2026

ASAC trial reveals aspirin fails to improve metastatic colorectal cancer survival

Colorectal cancer is one of the most common cancers worldwide, and up to half of patients develop liver metastases during the course of their disease.

5 Oct 2026

Is a high-protein diet hard on your kidneys?

From temporary changes in kidney filtration to the competing nutritional needs of older adults and children, researchers examine when high protein intake may shift from adaptation to concern.

5 Oct 2026

Poor nutrition scores predict mortality risk beyond body weight

In a population-based cohort of 8,398 adults in Leipzig, Germany, poorer nutritional status measured using several laboratory-based scores was associated with a higher risk of all-cause mortality over a median follow-up of about 7.5 years.

5 Oct 2026

Five lipids revealed a divide between active and inactive pregnancies

Staying active during pregnancy is linked to changes in DHA-rich placental lipids

5 Oct 2026

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle

Tirzepatide cuts body fat while preserving skeletal muscle in real-world study

2 Oct 2026

Could the gut be priming the body for a more severe stroke?

Gut bacteria may prime immune cells to worsen stroke damage

2 Oct 2026

$Vitamin B12 deficiency was linked to higher fracture hazard after 50$

Vitamin B12 deficiency was linked to higher fracture hazard after 50

A study links abnormal vitamin B12 levels to fracture risk, highlighting a complex relationship beyond simple deficiency in middle-aged and older adults.

2 Oct 2026

Faith leaders could help expand hypertension screening and education in Nigeria

A new study has shown that faith leaders would be willing to partner on hypertension screenings and education, despite challenges of past health collaborations.

1 Oct 2026

Very low carbohydrate diets show potential benefits in children with type 1 diabetes

Very low carbohydrate (VLC) diets may be associated with health benefits in children with type 1 diabetes (T1D) and were not associated with acute diabetes complications, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has found.

1 Oct 2026

European study demonstrates feasibility of population-wide type 1 diabetes screening

New research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) reports on pilot screening programs for type 1 diabetes from 8 different countries, and the authors – a consortium including Dr Peter Achenbach and Professor Anette-Gabriele Ziegler from the Institute of Diabetes Research, Helmholtz Munich, Munich, Germany – say that screening should be rolled out across Europe, ideally with three testing window: 2-4 years, 6-8 years and 10-15 years.

1 Oct 2026

CBL-514 injection reduces visceral and subcutaneous fat in trials

Details of a new injection that targets fat cells will be released at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2).

1 Oct 2026

Type 1 diabetes incidence rose by 11% after rotavirus vaccine rollout in Norway

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in Diabetologia (the journal of EASD) shows that incidence (the new case rate) of type 1 diabetes (T1D) in children aged 0.5-5 years in Norway was 11% higher following the rapid roll out and uptake of the rotavirus vaccine in September 2014.

1 Oct 2026

NIH-funded trials will test pregnenolone for addiction and depression

Center for BrainHealth investigator Francesca Filbey, PhD, and UTSW investigator Sherwood Brown, MD, PhD, have secured two awards from the National Institutes of Health (NIH) to fund two major collaborative studies investigating whether the naturally occurring neurosteroid pregnenolone can help treat substance use disorders and co-occurring depression.

1 Oct 2026